Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6794-6799

  Israël Assayag, Evelyne ^b   Fournier, Marcien ^b   Cormier, Yvon ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 4;

ALLERGIC PNEUMONITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; INFLAMMATORY DISEASE; LUNG LAVAGE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE ACTIVATION;

EID: 0345148993     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.163.12.6794     Document Type: Article

References (31)

1. Cormier, Y., and M. Schuyler. 1992. Part M: interstitial lung disease. In Hypersensitivity Pneumonitis Textbook of Pulmonary Medicine, Vol. 2, R. C. Bone, ed. Mosby-Year Book, St. Louis, pp. 1-9
2. Trentin, L., N. Migone, R. Zambello, P. Francia di Celle, F. Aina, C. Feruglio, P. Bulian, M. Masciarelli, C. Agostini, A. Cipriani, et al. 1990. Mechanisms accounting for lymphocytic alveolitis in hypersensitivity pneumonitis. J. Immunol. 144:2147.
3. Semenzato, G. 1991. Immunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis, and HIV infection. Eur. Respir. J. 4:94.
4. Suga, M., H. Yamasaki, K. Nakagawa, H. Kohrogi, and M. Ando. 1997. Mechanisms accounting for granulomatous responses in hypersensitivity pneumonitis. Sarcoidosis Vasc. Diffuse Lung Dis. 14:131.
5. Guillon, J. M., P. Joly, B. Autran, M. Denis, G. Akoun, P. Debré, and C. Mayaud. 1992. Minocyclin-induced cell-mediated hypersensitivity pneumonitis. Ann. Intern. Med. 117:476.
6. Schuyler, M., S. Subramanyan, and M. Hassan. 1987. Experimental hypersensitivity pneumonitis: transfer with cultured cells. J. Lab. Clin. Med. 109:623.
7. Wahlström, J., M. Berlin, R. Lundgren, O. Olerup, H. Wigzell, A. Eklund, and J. Grunewald. 1997. Lung and blood T cell receptor repertoire in extrinsic allergic alveolitis. Eur. Respir. J. 10:772.
8. Trentin, L., R. Zambello, M. Facco, C. Tassinari, R. Sancetta, M. Siviero, A. Cerutti, A. Cipriani, G. Marcer, M. Majori, et al. 1997. Selection of T lymphocytes bearing limited TCR-Vβ regions in the lung of hypersensitivity pneumonitis and sarcoidosis. Am. J. Respir. Crit. Care Med. 155:587.
9. + cells adoptively transfer experimental hypersensitivity pneumonitis. Cell. Immunol. 177:169.
10. Gudmundsson G, and G. W. Hunninghake. 1997. Interferon-γ is necessary for the expression of hypersensitivity pneumonitis. J. Clin. Invest. 99:2386.
11. Gudmundsson, G., M. M. Monick, and G. W. Hunninghake. 1998. IL-12 modulates expression of hypersensitivity pneumonitis. J. Immunol. 161:991.
12. Drent, M., J. C. Grutters, P. G. Mulder, H. van Velzen-Blad, E. F. Wouters, and J. M. van den Bosch. 1997. Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile? Sarcoidosis Vasc. Diffuse Lung Dis. 14:31.
13. Israël-Assayag, E., and Y. Cormier. 1999. Detection of intracellular cytokines of lung lymphocytes in human hypersensitivity pneumonitis (HP). Am. J. Respir. Crit. Care Med. 159:A741.
14. Boyd G., C. McSharry, K. McLeod, S. Sriram, and F. Boyd. 1999. Lymphocyte responses in pigeon breeders with extrinsic allergic alveolitis/hypersensitivity pneumonitis (EAA/HP) are predominantly T helper 2-type. Am. J. Respir. Crit. Care Med. 159:A742.
15. Lenschow, D. J., T.L. Walunas, and J.A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
16. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
17. Linsley, P. S., P. M. Wallace, J. Johnsom, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in-vivo by a soluble form of the CTLA4 T cell activation molecule. Science 257:792.
18. Thompson C. B. 1995. Distinct roles forthe costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979.
19. Schweitzer, A. N., and A. H. Sharpe. 1998. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J. Immunol. 161:2762.
20. Chelen, C. J., Y. Fang, G. J. Freeman, H. Secrist, J. D. Marshall, P. T. Hwang, L. R. Frankel, R. H. DeKruyff, and D. T. Umetsu. 1995. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J. Clin. Invest. 5:1415.
21. Zissel, G., M. Ernst, M. Schlaak, and J. Müller-Quernheim. 1997. Accessory function of alveolar macrophages from patients with sarcoïdosis and other granulomatous and nongranulomatous lung diseases. J. Invest. Med. 45:75.
22. Dakhama, A., E. Israël-Assayag, and Y. Cormier. 1996. Altered immuno-suppressive activity of alveolar macrophages in farmer's lung. Eur. Respir. J. 9:1456.
23. Israël-Assayag E., A. Dakhama, S. Lavigne, M. Laviolette, and Y. Cormier. 1999. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis: Am. J. Respir. Crit. Care Med. 159:1830.
24. Cormier, Y., G. Tremblay, M. Fournier, and E. Assayag. 1994. Longterm viral enhancement of lung response to Saccharapolyspora rectivirgula. Am. J. Respir. Crit. Care Med. 149:490.
25. Tsuyuki, S., J. Tsuyuki, K. Einsle, M. Kopf, and A. J. Coyle. 1997. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J. Exp. Med. 9:1671.
26. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long term survival of xenogeneic pancreatic islet graft induced by CTLA4-Ig. Science 257:789.
27. Finck, B. K., P. S. Linsley, and D. Wofsky. 1994. Treatment of murine lupus with CTLA4-Ig. Science 265:1225.
28. Krinzman S. J., G. T. De Sanctis., M. Cernadas, D. Mark, W. Wang, J. Listman, L. Kobzik, C. Donovan, K. Nassr, I. Katona, et al. 1996. Inhibition of T cell costimulation abrogates airway responsiveness in a murine model. J. Clin. Invest. 98:2693.
29. Abrams, J. R., M. G. Lebwohl, C. A. Guzzo, B. V. Jegasothy, M. T. Goldfarb, B. S. Goffe, A. Menter, N. J. Lowe, G. Krueger, M. J. Brown, R. S. Weiner, M. J. Birkhofer, G. L. Warner, K. K. Berry, P. S. Linsley, J. G. Krueger, H. D. Ochs, S. L. Kelley, and S. Kang. 1999. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103:1243.
30. Keane-Myers, A., W. C. Gause, P. Linsley, S. J. Chen, and M. Wills-Carp. 1997. B7-CD28/CTLA4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 158:2042.
31. Kasai, M., K. Kumano, K. Kurasawa, A. Nakao, Y. Saito, and Iwamoto. 1998. Blockade of CD28/B7 interaction suppresses allergic eosinophilic inflammation in mice. Int. Arch. Allergy Immunol. 117(Suppl 1):14.